ArticleKidney international reports2021

Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium.

Isa F Ashoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.